Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes

Experimental Gerontology

Volumn 36, Issue 3, 2001, Pages 547-557

  Giuliani, N ^a   Sansoni, P ^a   Girasole, G ^a   Vescovini, R ^a   Passeri, G ^a   Passeri, M ^a   Pedrazzoni, M ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Aging; Centenarians; Interleukin 6; Osteoporosis; Soluble gp130; Soluble IL 6 receptor

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ADULT; AGED; AGING; ARTICLE; BONE MASS; CONTROLLED STUDY; FEMALE; HUMAN; MENOPAUSE; NORMAL HUMAN; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AGING; FEMALE; HUMANS; INTERLEUKIN-6; MENOPAUSE; MIDDLE AGED; NEURAL CELL ADHESION MOLECULES; POSTMENOPAUSE; PREMENOPAUSE; RECEPTORS, INTERLEUKIN-6; REGRESSION ANALYSIS;

EID: 0035093402     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(00)00220-5     Document Type: Article

References (44)

1. Interleukin-6 in biology and medicine
2. Quantitative and qualitative alterations of acute-phase proteins in healthy elderly persons
3. IL-6-mediated events in Alzheimer's disease pathology
4. Quantification of bone alkaline phosphatase in serum by precipitation with wheat-germ lectin: a simplified method and its clinical plausibility
5. Increased production of tumor necrosis factor and interleukin-6 by arterial wall of aged rats
6. Non-trauma mortality in elderly women with low bone mineral density. Study of osteoporotic fractures research group
7. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative
8. Interleukin-6: a cytokine for gerontologists
9. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty
10. Increased cytokine production in mononuclear cells of healthy elderly people
11. Soluble interleukin 6 receptor in biological fluids from human origin
12. Circulating interleukin-6 receptor in patients with sepsis syndrome
13. Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy
14. Oestrogen prevent the increase of human serum soluble interleukin-6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro
15. Fibrinogen and aging
16. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
17. Increased soluble tumor necrosis factor receptor levels in the serum of elderly people
18. Increased osteoclast development after estrogen loss: mediation by interleukin-6
19. Perspective: the diagnosis of osteoporosis
20. Circulating cytokine levels in osteoporotic and normal women
21. Interleukin-6 family of cytokines and gp130
22. Interleukin-6 and its receptor: a paradigm for cytokines
23. Serum interleukin-6 and bone metabolism in patients with thyroid function disorders
24. Mechanisms of disease: bone marrow, cytokines, and bone remodeling - emerging insights into the pathophysiology of osteoporosis
25. Hypercoagulability in centenarians: the paradox of successful aging
26. Circulating levels of cytokines that modulate bone resorption: effects of age and menopause in women.
27. The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site
28. Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130
29. Quantitative intracellular cytokine measurement: age-related changes in proinflammatory cytokine production
30. Humoral immunity in aging
31. The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6
32. Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice
33. Genetic markers of bone metabolism and bone disease
34. Osteoclast function in Paget's disease and multiple myeloma
35. Soluble receptors for cytokines and growth factors: generation and biological function
36. Thymus function, ageing and autoimmunity
37. Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease
38. NK cell activity and T-lymphocyte proliferation in healthy centenarians
39. T lymphocyte proliferative capability to defined stimuli and costimulatory CD28 pathway is not impaired in healthy centenarians
40. Interleukin-6-type cytokines in vivo: regulated bioavailability
41. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6
42. Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse
43. Automated analysis of hydroxyproline with elimination of non-specific reacting substances
44. Increase of plasma IL-6 concentration with age in healthy subjects